CROFT JAMES AD 4

Accession 0001127602-10-007020

CIK 0000310142other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 11:16 AM ET

Size

29.8 KB

Accession

0001127602-10-007020

Form 4

Period: 2010-02-24

Director

Transactions

Exercise/Conversion
Common Stock
2010-02-24$20.07/sh+2,000$40,140→ 26,704.776 total
Exercise/Conversion
Stock Options (Right to Buy)
2010-02-24−2,000→ 0 total
Exercise: $20.46From: 2005-05-03Exp: 2014-05-03→ Common Stock (2,000 underlying)
Exercise/Conversion
Common Stock
2010-02-24$18.70/sh+2,000$37,400→ 20,704.776 total
Exercise/Conversion
Common Stock
2010-02-24$20.46/sh+2,000$40,920→ 24,704.776 total
Sale
Common Stock
2010-02-24$26.79/sh−10,000$267,852→ 18,704.776 total
Exercise/Conversion
Stock Options (Right to Buy)
2010-02-24−2,000→ 0 total
Exercise: $18.70From: 2002-05-01Exp: 2011-05-01→ Common Stock (2,000 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2010-02-24−2,000→ 0 total
Exercise: $21.66From: 2004-05-01Exp: 2013-05-01→ Common Stock (2,000 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2010-02-24−2,000→ 0 total
Exercise: $20.07From: 2006-05-02Exp: 2015-05-02→ Common Stock (2,000 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2010-02-24−2,000→ 0 total
Exercise: $20.25From: 2007-05-01Exp: 2016-05-01→ Common Stock (2,000 underlying)
Exercise/Conversion
Common Stock
2010-02-24$21.66/sh+2,000$43,320→ 22,704.776 total
Exercise/Conversion
Common Stock
2010-02-24$20.25/sh+2,000$40,500→ 28,704.776 total

Holdings

Common Stock
(indirect: By Spouse)
1,500
Stock Options (Right to Buy)
Exercise: $25.19From: 2003-05-01Exp: 2012-05-01→ Common Stock (2,000 underlying)
2,000
Stock Options (Right to Buy)
Exercise: $30.07From: 2009-05-01Exp: 2018-05-01→ Common Stock (2,000 underlying)
2,000
Stock Options (Right to Buy)
Exercise: $26.12From: 2008-05-01Exp: 2017-05-01→ Common Stock (2,000 underlying)
2,000

Footnotes (8)

[F1]Exercise of in-the-money stock option that would otherwise expire on 5/1/2011, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
[F2]Includes shares of restricted stock held under Issuer's 2002 Non-Employee Director Stock Plan and shares held in a dividend reinvestment plan.
[F3]Exercise of in-the-money stock option that would otherwise expire on 5/1/2013, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
[F4]Exercise of in-the-money stock option that would otherwise expire on 5/3/2014, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
[F5]Exercise of in-the-money stock option that would otherwise expire on 5/2/2015, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
[F6]Exercise of in-the-money stock option that would otherwise expire on 5/1/2016, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
[F7]This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $26.66 to $26.90. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F8]Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.

Documents

1 file

SENSIENT TECHNOLOGIES CORP

CIK 0000310142

Entity typeother